This patient still developed a large foveal subhyaloid hemorrhage despite very full prior panretinal photocoagulation (PRP).
Learning Points:
PRP has been around since the 1960s and still remains the mainstay for treating proliferative disease. Often considered a “one and done,” patients can still develop break-through hemorrhages. Intravitreal anti-VEGF injections are often helpful, but some will require vitrectomy.
